Findings from a recent study showed a drug-device combination product containing cantharidin, 0.7%, was safe and effective for patients with molluscum contagiosum.

Findings from a recent study highlighted whether Nd:YAG laser, CO2 laser, or pulse dye laser were effective for preventing recurrence of nonmelanoma skin cancers.

A recent study found rituximab infusions were associated with changes in heart rate and other cardiac adverse effects among patients with pemphigus.

Findings from a recent study showed biologic treatments were able to reduce coronary artery plaque lipid-rich necrotic core, which is associated with higher risk of cardiovascular events.

Findings from a post hoc analysis of two clinical trials showed improvements on psoriasis severity were comparable between patients with and without metabolic syndrome.

A recent clinical trial showed a topical foam was safe and effective for proactively managing psoriasis for 52 weeks.

Findings from a recent study showed the presence of dermal tunnels affected time to clinical response, as well as time to loss of response, among patients with hidradenitis suppurativa treated with adalimumab.

Findings from a recent study showed dupilumab was safe and effective for treating treatment-resistant atopic dermatitis over a year in a real-world setting.

Findings from a recent study suggest patients with metastatic melanoma treated immune checkpoint inhibitors are still at risk of developing new primary cutaneous melanoma.

A recent study highlighted factors, including smoking status, that affected disease severity among two large cohorts of patients with palmoplantar pustulosis.